Afuresertib plus fulvestrant for pretreated HR-positive, HER2-negative, advanced breast cancer: a phase Ib trial
- Pin Zhang
- Tao Sun
- Ying Wang
- Wei Li
- Zhongsheng Tong
- Sneha Phadke
- Trevor Feinstein
- Wenyue Ma
- Pengfei Guo
- Minhua Zhang
- Yong Yue
- Binghe Xu
2026-02-06